Network / IALSA

Integrative Analysis of Longitudinal Studies of Aging
  1. Home
  2. Networks
  3. IALSA

Integrative Analysis of Longitudinal Studies of Aging

IALSA logo
Studies 7
Datasets -
Variables -
Initiatives 0
Protocols -
Dataschemas -
Visit IALSA
Add to cart

Members

Investigators Contacts
  • Prof. Diana Kuh
    UCL School of Life and Medical Sciences
  • Andrea Piccinin, PhD.
    University of Victoria
  • Jeffrey Kaye, MD.
    Oregon Health & Science University
  • Scott M. Hofer, PhD.
    Oregon Health & Science University
  • Andrea Piccinin, PhD.
    University of Victoria
  • Scott M. Hofer, PhD.
    Oregon Health & Science University

Summary Statistics

No graphics available

Individual Studies

Acronym Name Study design Participants Countries
CLSA Canadian Longitudinal Study on Aging Cohort 50,000 Canada
CLS Canberra Longitudinal Study Cohort 1,045 Australia
SHIP Study of Health in Pomerania Cohort 8,728 Germany
LBLS Long Beach Longitudinal Study Cohort 2,125 United States of America
NuAge Quebec Longitudinal Study on Nutrition and Successful Aging Cohort 1,793 Canada
LASA Longitudinal Aging Study Amsterdam Cohort 5,132 Netherlands
ULSAM Uppsala Longitudinal Study of Adult Men Cohort 2,322 Sweden

Classifications

Socio-demographic and economic characteristics 7
Lifestyle and health behaviours 7
Health status and functional limitations 6
Diseases 7
Symptoms and signs 6
Medication and supplements 6
Non-pharmacological interventions 4
Health and community care utilization 5
Reproduction 4
Birth, infancy and childhood 2
End of life 3
Physical measures 6
Cognition, personality and other psychological measures 6
Laboratory measures 3
Social environment 5
Physical environment 5
Administrative information 7

Socio-demographic and economic characteristics 7

Age/birthdate 7
Sex/gender 6
Marital/partner status 6
Education 6
Birth place 3
Citizenship and immigrant status 3
Ethnicity, race and religion 4
Language 3
Residence 4
Family and household structure 6
Labour force and retirement 6
Income, possessions, and benefits 5

Lifestyle and health behaviours 7

Tobacco 7
Alcohol 7
Illicit drugs 1
Nutrition 4
Physical activity 5
Transportation 2
Personal hygiene 1
Sleep 2
Leisure activities 3
Other information on lifestyle 1

Health status and functional limitations 6

Perception of health 4
Quality of life 2
Functional activities 6
Use of assistive devices 5
Other information about health status 1

Diseases 7

Certain infectious and parasitic diseases (A00-B99) 1
Neoplasms (C00-D48) 4
Blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89) 2
Endocrine, nutritional and metabolic diseases (E00-E90) 6
Mental and behavioural disorders (F00-F99) 2
Nervous system (G00-G99) 3
Eye and adnexa (H00-H59) 4
Ear and mastoid process (H60-H95) 3
Circulatory system (I00-I99) 6
Respiratory system (J00-J99) 4
Digestive system (K00-K93) 3
Skin and subcutaneous tissue (L00-L99) 2
Musculoskeletal system and connective tissue (M00-M99) 3
Genitourinary system (N00-N99) 4
Injury, poisoning and certain other consequences of external causes (S00-T98) 3
External causes of morbidity and mortality (V01-Y98) 4
Diseases without precise specification or related to multiple categories 5

Symptoms and signs 6

Circulatory and respiratory systems (R00-R09) 3
Digestive system and abdomen (R10-R19) 3
Nervous and musculoskeletal systems (R25-R29) 1
Urinary system (R30-R39) 1
Cognition, perception, emotional state and behaviour (R40-R46) 4
Speech and voice (R47-R49) 1
General symptoms and signs (R50-R69) 2
Symptoms related to multiple categories 1

Medication and supplements 6

Medication and supplements 6
Posology and protocol of administration 1
Other and unspecified pharmacological interventions 2

Non-pharmacological interventions 4

Surgical interventions 2
Radiological interventions 1
Physical therapy interventions 2
Cognitive, psychological and sensory interventions 3
Educational and health promotion interventions 1
Biosample analyses 1
Other information on non-pharmacological interventions 4

Health and community care utilization 5

Visits to health professionals 5
Hospitalizations 4
Community care 3

Reproduction 4

Menstruation, menopause and andropause 3
Contraception and family planning 1
Pregnancy, labour, delivery, and postpartum characteristics 1
Gravidity, pregnancy outcomes, parity (female) and fertility (male) 4

Birth, infancy and childhood 2

Newborn/infant characteristics 1
Other infant/child related information 2

End of life 3

Vital status 3
Cause of death 2
Palliative care 1
Other end of life or death related information 1

Physical measures 6

Physical characteristics 2
Anthropometry 6
Circulation and respiration 4
Muscles, skeleton and mobility 3
Sensory and pain 1
Skin and subcutaneous tissue 2

Cognition, personality and other psychological measures 6

Cognitive functioning 5
Psychological distress and emotions 6
Personality 2
Other psychological measures 5

Laboratory measures 3

Hematology 2
Biochemistry 3
Immunology 1
Toxicology 1
Histology 1

Social environment 5

Social network 5
Social participation 5
Social support 5
Life events and plans 4
Other social environment characteristics 3

Physical environment 5

Housing characteristics 4
Built environment/neighbourhood characteristics 3
Chemical exposure 2
Other physical environment characteristics 1

Administrative information 7

Identifiers 5
Date and time 5
Questionnaire / Interview related information 3
Physical and cognitive measures and biosample related information 3
Data and sample collection center characteristics 4
Other administrative information 4